DR5 (Conatumumab) Recombinant Monoclonal Antibody
Product Specifications
Gene Aliases
Rotein antibody; Apoptosis inducing protein TRICK2A/2B antibody; Apoptosis inducing receptor TRAIL R2 antibody; CD262 antibody; CD262 antigen antibody; Cytotoxic TRAIL receptor 2 antibody; Death domain containing receptor for TRAIL/Apo 2L antibody; Death receptor 5 antibody; DR5 antibody; KILLER antibody; KILLER/DR5 antibody; OTTHUMP00000123492 antibody; OTTHUMP00000123493 antibody; p53 regulated DNA damage inducible cell death receptor (killer) antibody; TNF related apoptosis inducing ligand receptor 2 antibody; TNF-related apoptosis-inducing ligand receptor 2 antibody; TNFRSF10B antibody; TR10B_HUMAN antibody; TRAIL R2 antibody; TRAIL receptor 2 antibody; TRAIL-R2 antibody; TRAILR2 antibody; TRICK2 antibody; TRICK2A antibody; TRICK2B antibody; TRICKB antibody; Tumor necrosis factor receptor like protein ZTNFR9 antibody; Tumor necrosis factor receptor superfamily member 10B antibody; Tumor necrosis factor receptor superfamily; member 10b antibody; ZTNFR9 antibody; Conatumumab
UniProt
O14763
Antigen Species
Human
Reactivity
Human
Target Antigen
Recombinant Human DR5 protein
Target
TNFRSF10B
Clonality
Monoclonal
Conjugation
Non-conjugated
Field of Research
Cancer; Cardiovascular; Cell biology; Signal transduction
Purification Method
Affinity-chromatography
Form
Liquid
Storage Conditions
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Antibody Type
Recombinant Antibody
Clone ID
1D10
Tested Applications
ELISA; Recommended dilution: ELISA:1:5000-1:50000
Isotype
IgG1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
